Stock Track | Lantheus Plummets 5% as Truist Securities Downgrades to Hold, Slashes Price Target

Stock Track
08/13

Shares of Lantheus Holdings (LNTH) plummeted 5.03% in intraday trading on Tuesday following a significant downgrade from Truist Securities. The investment firm cut its rating on Lantheus from Buy to Hold and dramatically reduced its price target from $111 to $63, triggering a sell-off in the stock.

The downgrade comes as a substantial shift in Truist Securities' outlook for Lantheus, a company known for its diagnostic imaging agents and products. The sharp reduction in the price target, nearly halving the previous estimate, suggests that the analysts at Truist have reassessed their expectations for Lantheus' future performance and growth prospects.

Prior to this downgrade, Lantheus had maintained a generally positive outlook among analysts. According to FactSet data, the company had an average rating of "Buy" with a mean price target of $92. The stark contrast between Truist's new stance and the overall market sentiment underscores the potential impact of this downgrade on investor confidence, as reflected in today's significant stock price decline.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10